{"@context":{"@vocab":"https://schema.org/"},"@type":"Drug","@id":"https://api.morvs.ai/drug-product/0173-0882#drug","name":"Breo Ellipta","alternateName":"fluticasone furoate and vilanterol trifenatate","identifier":[{"@type":"PropertyValue","propertyID":"FDA National Drug Code (NDC)","value":"0173-0882"},{"@type":"PropertyValue","propertyID":"FDA application number","value":"NDA204275"},{"@type":"PropertyValue","propertyID":"UNII","value":"JS86977WNV|40AHO2C6DG"},{"@type":"PropertyValue","propertyID":"SPL Set ID","value":"96428df1-ea05-431a-98d3-1ec2c4b63878"}],"activeIngredient":"FLUTICASONE FUROATE, VILANTEROL TRIFENATATE","administrationRoute":["RESPIRATORY (INHALATION)"],"dosageForm":"POWDER","manufacturer":{"@type":"Organization","name":"GlaxoSmithKline LLC"},"drugClass":[],"isAvailableGenerically":false,"legalStatus":"HUMAN PRESCRIPTION DRUG","sameAs":["https://api.morvs.ai/drug-approval/NDA204275","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=96428df1-ea05-431a-98d3-1ec2c4b63878","https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0173-0882"],"isAccessibleForFree":true,"license":"https://creativecommons.org/publicdomain/zero/1.0/","_source":{"data_provider":"AI Analytics","brand_name":"MORVS","brand_url":"https://morvs.ai/","data_provider_url":"https://api.morvs.ai","license":"https://creativecommons.org/publicdomain/zero/1.0/","primary_source":"https://open.fda.gov/apis/drug/ndc/","generated_at":"2026-11-15T05:20:52.749Z"}}